Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Researchers identify new PET imaging biomarker capable of predicting immunotherapy success
A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers.
New PET agent offers 'exceptional' imaging of kidney cancer
The agent was found to be better than standard CT imaging for patients with clear cell renal cell cancer.
Imaging agent that targets deadly brain tumors given FDA's Fast Track designation
Fast Track designations are typically granted to drugs that target an unmet medical need.
PET/MRI may reduce unnecessary prostate biopsies by 83%
A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.
AI able to assess invasiveness of lung lesions to aid in surgery
In a study, the most accurate model combined deep-learning with a radionomics approach.

High-intensity focused ultrasound offers noninvasive treatment for cancer patients

High-intensity focused ultrasound (HIFU) may have the potential to replace drug therapy for cancer patients when combined with surgery, radiation therapy or chemotherapy, according to new research published online in the March-April 2018 issue of Radiographics.

March 19, 2018

Point-of-care device may upend traditional thyroid cancer screening methods

A group of international researchers has developed a point-of-care device that may produce a consistent and cost-effective screening method for thyroid nodules.

March 19, 2018

Disparities based on age, race persist in PET use for lung cancer patients

Demographic differences in the use of PET imaging among Medicare beneficiaries with non-small cell lung cancer have persisted since the modality’s approval by Medicare in 1998, according to a study published online Feb. 15 in Radiology.

February 19, 2013

Oncology Imaging

Researchers identify new PET imaging biomarker capable of predicting immunotherapy success

New PET agent offers 'exceptional' imaging of kidney cancer

Imaging agent that targets deadly brain tumors given FDA's Fast Track designation

PET/MRI may reduce unnecessary prostate biopsies by 83%

AI able to assess invasiveness of lung lesions to aid in surgery